Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Non-Muscle Invasive Bladder Neoplasms × Ty21a typhoid vaccine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1

Interventions

vocimagene amiretrorepvec 1 enfortumab vedotin 1 catumaxomab 1 apatorsen 1 Ty21a typhoid vaccine 1 Therapeutics 1 Photochemotherapy 1 Paclitaxel 1 Mitomycin 1 Imiquimod 1 Gemcitabine 1 Flucytosine 1 Ethacrynic Acid 1 Bevacizumab 1 BCG Vaccine 1 Antibodies 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03421236 2021-04-28

Intravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

University of Lausanne Hospitals

Phase 1 Unknown

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡